This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
HK$0.10
Share price
-33.50%
Change (1 day)
-98.91%
Change (1 year)
Categories
Market capitalization of Athersys (ATHX)
Last known market cap: HK$6.46 Million
On March 12, 2024 Athersys had a market cap of HK$6.46 Million. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Athersys from 2007 to 2024
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2024 | HK$6.46 M | -32.9% |
| 2023 | HK$9.64 M | -91.46% |
| 2022 | HK$0.11 B | -93.18% |
| 2021 | HK$1.65 B | -39.58% |
| 2020 | HK$2.74 B | 79.01% |
| 2019 | HK$1.53 B | -5.93% |
| 2018 | HK$1.62 B | -2.93% |
| 2017 | HK$1.67 B | 64.67% |
| 2016 | HK$1.01 B | 52.31% |
| 2015 | HK$0.66 B | -29.82% |
| 2014 | HK$0.95 B | -30.5% |
| 2013 | HK$1.37 B | 214.32% |
| 2012 | HK$0.43 B | 38.04% |
| 2011 | HK$0.31 B | -13.21% |
| 2010 | HK$0.36 B | -39.97% |
| 2009 | HK$0.60 B | 820.75% |
| 2008 | HK$65.83 M | -90.91% |
| 2007 | HK$0.72 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | HK$1.179 T | 18,238,154.29% | 🇺🇸 USA |
 | HK$970.29 B | 15,002,097.84% | 🇺🇸 USA |
 | HK$779.62 B | 12,054,075.87% | 🇺🇸 USA |
 | HK$75.59 B | 1,168,766.84% | 🇺🇸 USA |
 | HK$2.879 T | 44,514,867.15% | 🇺🇸 USA |
 | HK$20.38 B | 315,098.65% | 🇺🇸 USA |
 | HK$47.85 B | 739,854.52% | 🇺🇸 USA |
 | HK$1.493 T | 23,091,890.92% | 🇺🇸 USA |
 | HK$984.74 B | 15,225,554.19% | 🇫🇷 France |